[Indications for methylergonovine tartrate in delivery, cesarean section, curettage and puerperium].
D002585:Cesarean Section; D003475:Curettage; D036861:Delivery, Obstetric; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008755:Methylergonovine; D010120:Oxytocics; D049590:Postpartum Period / Q000150:complications*; D011247:Pregnancy; D013644:Tartrates; D014599:Uterus / Q000601:surgery*
D004876:Ergot Alkaloids; D010120:Oxytocics; D013644:Tartrates; C029768:tartaric acid; D008755:Methylergonovine
CESAREAN SECTION; DELIVERY; ERGOT ALKALOIDS/therapeutic use; PUERPERIUM/complications; UTERUS/surgery
Les indications du tartrate de méthyl-ergobasine au cours de la délivrance, de la césarienne, du curetage et des suites de couches.